Clinical Study of Sintilimab as Second-Line or Above Therapy in Patients With Advanced or Metastatic Gastric Cancer: A Retrospective Study

BACKGROUND: The present study was conducted to analyze the clinical efficacy and safety of sintilimab as second-line or above therapy for patients with advanced or metastatic gastric cancer. METHODS: Patients with advanced or metastatic gastric cancer that progressed after prior systemic therapies a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Caiyun, Lv, Huifang, Liu, Yingjun, Chen, Beibei, Xu, Weifeng, Wang, Jianzheng, Chen, Xiaobing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494388/
https://www.ncbi.nlm.nih.gov/pubmed/34631579
http://dx.doi.org/10.3389/fonc.2021.741865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494388/
https://www.ncbi.nlm.nih.gov/pubmed/34631579
http://dx.doi.org/10.3389/fonc.2021.741865

Ejemplares similares